[Form 4] SCHWAB CHARLES CORP Insider Trading Activity
Charles Schwab’s MD and Chief Banking Officer Paul V. Woolway reported a mix of equity awards, option activity, and insider sales in company stock.
Rhea-AI Filing Summary
Charles Schwab’s MD and Chief Banking Officer Paul V. Woolway reported a mix of equity awards, option activity, and insider sales in company stock. Across several open-market transactions executed through a trust, he sold 22,010 shares of common stock, with prices in the mid‑$90s, under a pre‑arranged Rule 10b5‑1 trading plan. The filing also shows shares acquired from vesting of performance-based restricted stock units tied to a three-year goal period ending December 31, 2025, the exercise of a nonqualified stock option, a new stock option grant, and shares withheld to cover related tax obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
12 txns
Insider
Woolway Paul V
Role
MD, Chief Banking Officer
Sold
22,010 shs ($2.09M)
Approx. gross sale proceeds
$2.09M
Approx. exercise cost
$827K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,626 | $94.4144 | $342K |
| Sale | Common Stock | 2,500 | $94.8904 | $237K |
| Exercise | Nonqualified Stock Option (right to buy) | 15,884 | $0.00 | $0.00 |
| Grant/Award | Nonqualified Stock Option (right to buy) | 15,189 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,884 | $52.05 | $827K |
| Sale | Common Stock | 7,942 | $94.23 | $748K |
| Sale | Common Stock | 7,942 | $96.0013 | $762K |
| Grant/Award | Common Stock | 8,156 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,030 | $90.305 | $183K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Nonqualified Stock Option (right to buy) — 31,072 contracts (Direct);
Common Stock — 25,153 shares (Direct);
Common Stock — 29,866.4372 shares (Indirect, by Trust);
Common Stock — 7,500 shares (Indirect, by ESPP);
Common Stock — 1,536.624 shares (Indirect, by Son 1);
Common Stock — 1,536.624 shares (Indirect, by Son 2)
Footnotes (9)
- F1. Shares acquired on the vesting of performance-based restricted stock units ("PBRSUs") granted under the company's 2022 Stock Incentive Plan, reflecting the achievement by the reporting person of the performance goal over a three-year performance period ended December 31, 2025.
- F2. The company withheld shares of common stock from the reporting person to pay the tax withholding obligations related to the vesting of the PBRSUs.
- F3. Reflects the contribution of 15,884 shares received upon exercise of the options to a revocable trust.
- F4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on November 24, 2025.
- F5. This transaction was executed in multiple trades at prices ranging from $96.00 to $96.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $93.7 to $94.695. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- F7. This transaction was executed in multiple trades at prices ranging from $94.72 to $95.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- F8. The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.
- F9. The option was granted under the company's 2022 Stock Incentive Plan and vests in four equal annual installments beginning on the first anniversary of the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
